Total Payments
$1,933
2024 Payments
$26.35
Companies
15
Transactions
116
Medicare Patients
2,945
Medicare Billing
$202,706
Payment Breakdown by Category
Food & Beverage$1,821 (94.2%)
Education$111.81 (5.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,821 | 110 | 94.2% |
| Education | $111.81 | 6 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $746.05 | 46 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $454.72 | 31 | $0 (2020) |
| GlaxoSmithKline, LLC. | $153.10 | 7 | $0 (2024) |
| Novo Nordisk Inc | $141.44 | 9 | $0 (2020) |
| Lilly USA, LLC | $97.50 | 6 | $0 (2022) |
| Astellas Pharma US Inc | $85.00 | 1 | $0 (2018) |
| Amgen Inc. | $80.96 | 5 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $47.98 | 3 | $0 (2018) |
| PFIZER INC. | $34.27 | 2 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.21 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.35 | 1 | GlaxoSmithKline, LLC. ($26.35) |
| 2023 | $45.34 | 2 | Amgen Inc. ($27.22) |
| 2022 | $73.90 | 4 | GlaxoSmithKline, LLC. ($27.83) |
| 2021 | $127.41 | 8 | AstraZeneca Pharmaceuticals LP ($44.86) |
| 2020 | $301.85 | 19 | AstraZeneca Pharmaceuticals LP ($113.02) |
| 2019 | $368.93 | 22 | AstraZeneca Pharmaceuticals LP ($248.42) |
| 2018 | $546.98 | 29 | AstraZeneca Pharmaceuticals LP ($208.95) |
| 2017 | $441.80 | 31 | Boehringer Ingelheim Pharmaceuticals, Inc. ($172.96) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: RESPIRATORY | ||||||
| 04/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: RESPIRATORY | ||||||
| 03/08/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: Cardiology | ||||||
| 10/19/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Diabetes | ||||||
| 10/05/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Inflammation | ||||||
| 09/22/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/04/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: RESPIRATORY | ||||||
| 12/08/2021 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Inflammation | ||||||
| 10/27/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Diabetes | ||||||
| 09/29/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Cardiology | ||||||
| 07/28/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: RESPIRATORY | ||||||
| 06/01/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Respiratory | ||||||
| 04/14/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: RESPIRATORY | ||||||
| 03/10/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/13/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: DIABETES | ||||||
| 12/02/2020 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Inflammation | ||||||
| 11/12/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Diabetes | ||||||
| 08/19/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Diabetes | ||||||
| 08/05/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/22/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 553 | 1,194 | $67,495 | $40,357 |
| 2022 | 9 | 687 | 1,427 | $78,304 | $45,980 |
| 2021 | 8 | 669 | 1,666 | $84,017 | $52,174 |
| 2020 | 10 | 1,036 | 2,297 | $125,074 | $64,195 |
Total Patients
2,945
Total Services
6,584
Medicare Billing
$202,706
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 156 | 324 | $29,160 | $16,877 | 57.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 126 | 200 | $25,800 | $16,081 | 62.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 50 | 50 | $6,800 | $6,024 | 88.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 45 | 45 | $900.00 | $758.25 | 84.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 54 | 107 | $1,605 | $343.47 | 21.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 27 | 39 | $585.00 | $132.99 | 22.7% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 25 | 25 | $625.00 | $107.25 | 17.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 70 | 404 | $2,020 | $32.96 | 1.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 190 | 445 | $39,765 | $22,841 | 57.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 112 | 150 | $19,350 | $11,142 | 57.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 79 | 79 | $10,744 | $9,706 | 90.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 49 | 49 | $980.00 | $825.84 | 84.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 15 | $1,050 | $589.32 | 56.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 67 | 121 | $1,815 | $392.65 | 21.6% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 62 | 62 | $1,550 | $268.01 | 17.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 38 | 52 | $780.00 | $178.80 | 22.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 75 | 454 | $2,270 | $36.47 | 1.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 206 | 535 | $46,525 | $29,539 | 63.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 110 | 143 | $18,447 | $11,694 | 63.4% |